1. Home
  2. LOB vs ORIC Comparison

LOB vs ORIC Comparison

Compare LOB & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

N/A

Current Price

$31.91

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

N/A

Current Price

$7.39

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOB
ORIC
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
LOB
ORIC
Price
$31.91
$7.39
Analyst Decision
Buy
Strong Buy
Analyst Count
5
16
Target Price
★ $40.50
$21.29
AVG Volume (30 Days)
262.1K
★ 1.8M
Earning Date
10-21-2026
11-16-2026
Dividend Yield
★ 0.37%
N/A
EPS Growth
★ 31.95
19.67
EPS
★ 1.86
N/A
Revenue
N/A
N/A
Revenue This Year
$12.75
N/A
Revenue Next Year
$13.70
N/A
P/E Ratio
$17.59
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.18
$7.23
52 Week High
$44.53
$14.68

Technical Indicators

Market Signals
Indicator
LOB
ORIC
Relative Strength Index (RSI) 29.22 31.88
Support Level $31.44 N/A
Resistance Level $38.49 $14.23
Average True Range (ATR) 1.14 0.62
MACD -0.15 -0.05
Stochastic Oscillator 0.21 2.54

Price Performance

Historical Comparison
LOB
ORIC

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: